Securities and Exchange Commission
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(A)
of the Securities Exchange Act of 1934
Filed by the Registrant [ ]
Filed by a Party other than the Registrant [X]
Check the appropriate box:
[] Preliminary Proxy Statement
[ ] Definitive Proxy Statement
[X] Definitive Additional Materials
[ ] Soliciting Material Pursuant to Section 240.14a-11(c)
or Section 240.14a-12
Circon Corporation
(Name of Registrant as Specified in its Charter)
United States Surgical Corporation
(Name of Person Filing Proxy Statement)
----------------------------
Payment of Filing Fee (Check the appropriate box):
[X] No fee required.
[ ] Fee computed on table below per Exchange Act Rules
14a-6(i)(4) and 0-11.
(1) Title of each class of securities to which
transaction applies: N/A
(2) Aggregate number of securities to which
transaction applies: N/A
(3) Per unit price or other underlying value of
transaction computed pursuant to Exchange Act Rule
0-11 (Set forth the amount on which the filing fee
is calculated and state how it was determined): N/A
(4) Proposed maximum aggregate value of transaction:
N/A
(5) Total fee paid: N/A
[ ] Fee previously paid with preliminary materials.
[ ] Check box if any part of the fee is offset as
provided by Exchange Act Rule 0-11(a)(2) and
identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by
registration statement number, or the Form or
Schedule and the date of its filing.
(1) Amount previously paid:
(2) Form, Schedule or Registration Statement Number:
(3) Filing Party:
(4) Date Filed:
FOR IMMEDIATE RELEASE: September 16, 1997
INVESTOR CONTACT: U.S. SURGICAL HOME PAGE MEDIA CONTACT:
Marianne Scipione http://www.ussurg.com Steve Rose
Vice President Director
Corporate Communications Media Relations
(203) 845-1404 (203) 845-1732
[email protected] [email protected]
UNITED STATES SURGICAL CORPORATION
FILES SUIT AGAINST CIRCON CORPORATION
NORWALK, CT. -- United States Surgical Corporation
(NYSE:USS) said today that it has filed suit against Circon
Corporation (NASDAQ: CCON) in the Court of Chancery in the
State of Delaware seeking to enjoin Circon from reappointing
Richard Auhll, Chairman, President and CEO, to the Circon Board
after he is voted out of office at the 1997 Circon Annual Meeting
on October 6, 1997.
USS announced that its amended complaint also is
seeking to declare void the Board's appointments earlier this
year of George Cloutier and R. Bruce Thompson to the Circon
Board and placing both of them in a class that is not up for
election this year.
The lawsuit alleges, among other things, that by
taking these actions the Circon Board is determined to ignore
the results of the stockholder vote and has breached its
fiduciary duties to the stockholders of Circon for the purpose
of disenfranchising stockholders and preventing them from
exercising their fundamental right to vote incumbent management
off the Board.
United States Surgical Corporation is a diversified
surgical products company specializing in minimally invasive
technologies that improve patient care and lower health costs.
